GEODE CAPITAL MANAGEMENT, LLC - CTI BIOPHARMA CORP ownership

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q4 2016$472,000
+11.3%
1,169,997
+3.3%
0.00%
Q3 2016$424,000
+10.4%
1,133,041
+0.1%
0.00%
Q2 2016$384,000
-45.3%
1,131,581
-14.3%
0.00%
Q1 2016$702,000
-48.1%
1,321,080
+20.0%
0.00%
-100.0%
Q4 2015$1,353,000
-6.2%
1,100,737
+11.4%
0.00%0.0%
Q3 2015$1,442,000
-22.3%
988,338
+3.8%
0.00%0.0%
Q2 2015$1,856,000
+15.9%
952,138
+7.6%
0.00%0.0%
Q1 2015$1,601,000
-16.8%
884,682
+8.5%
0.00%0.0%
Q4 2014$1,925,000
-0.4%
815,738
+2.2%
0.00%0.0%
Q3 2014$1,932,000
-8.0%
798,511
+6.9%
0.00%0.0%
Q2 2014$2,099,000747,2910.00%
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q1 2017.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders